Published in Nature Medicine · View the paper (DOI)
A new off-the-shelf vaccine has shown encouraging early results as a potential treatment for patients with pancreatic or colorectal cancer who have certain KRAS gene mutations. The vaccine appears to stimulate the immune system to create cancer-fighting cells, delaying cancer recurrence in some patients.
Coverage from 2 institutions